Meeder Asset Management Inc. Acquires 66,516 Shares of Endo International PLC (ENDP)

Meeder Asset Management Inc. grew its holdings in Endo International PLC (NASDAQ:ENDP) (TSE:ENL) by 23,503.9% in the 3rd quarter, HoldingsChannel reports. The fund owned 66,799 shares of the company’s stock after purchasing an additional 66,516 shares during the quarter. Meeder Asset Management Inc.’s holdings in Endo International were worth $1,124,000 as of its most recent SEC filing.

A number of other hedge funds have also bought and sold shares of ENDP. Xact Kapitalforvaltning AB grew its position in Endo International by 44.5% in the first quarter. Xact Kapitalforvaltning AB now owns 29,215 shares of the company’s stock worth $174,000 after acquiring an additional 9,000 shares in the last quarter. James Investment Research Inc. boosted its holdings in shares of Endo International by 594.9% during the 3rd quarter. James Investment Research Inc. now owns 10,945 shares of the company’s stock worth $184,000 after buying an additional 9,370 shares during the period. Harvest Fund Management Co. Ltd bought a new stake in shares of Endo International during the 3rd quarter worth $223,000. First Hawaiian Bank bought a new stake in shares of Endo International during the 3rd quarter worth $358,000. Finally, United Services Automobile Association boosted its holdings in shares of Endo International by 16.7% during the 2nd quarter. United Services Automobile Association now owns 41,508 shares of the company’s stock worth $391,000 after buying an additional 5,933 shares during the period. 98.43% of the stock is owned by institutional investors.

Shares of Endo International stock opened at $13.19 on Friday. Endo International PLC has a fifty-two week low of $5.27 and a fifty-two week high of $18.50. The firm has a market capitalization of $3.84 billion, a price-to-earnings ratio of 3.43, a P/E/G ratio of 1.65 and a beta of 0.65.

Endo International (NASDAQ:ENDP) (TSE:ENL) last issued its quarterly earnings results on Thursday, November 8th. The company reported $0.71 earnings per share for the quarter, beating analysts’ consensus estimates of $0.59 by $0.12. Endo International had a negative net margin of 34.72% and a positive return on equity of 237.45%. The firm had revenue of $745.00 million during the quarter, compared to the consensus estimate of $694.93 million. During the same period in the prior year, the firm earned $0.91 EPS. The business’s revenue was down 5.3% on a year-over-year basis. On average, equities research analysts predict that Endo International PLC will post 2.6 earnings per share for the current year.

In other Endo International news, Director Roger H. Kimmel sold 26,074 shares of the stock in a transaction on Tuesday, August 14th. The shares were sold at an average price of $15.90, for a total value of $414,576.60. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.80% of the stock is owned by corporate insiders.

Several analysts recently issued reports on the stock. Deutsche Bank set a $11.00 price objective on shares of Endo International and gave the stock a “buy” rating in a report on Wednesday, July 18th. ValuEngine raised shares of Endo International from a “strong sell” rating to a “sell” rating in a report on Wednesday, July 25th. BidaskClub downgraded shares of Endo International from a “strong-buy” rating to a “buy” rating in a report on Saturday, September 8th. Morgan Stanley upped their price objective on shares of Endo International from $7.00 to $17.00 and gave the stock an “equal weight” rating in a report on Friday, August 17th. Finally, Zacks Investment Research downgraded shares of Endo International from a “buy” rating to a “hold” rating in a report on Tuesday, September 18th. One investment analyst has rated the stock with a sell rating, fifteen have given a hold rating, five have assigned a buy rating and two have assigned a strong buy rating to the stock. Endo International has an average rating of “Hold” and a consensus target price of $14.58.

ILLEGAL ACTIVITY NOTICE: “Meeder Asset Management Inc. Acquires 66,516 Shares of Endo International PLC (ENDP)” was published by WKRB News and is the property of of WKRB News. If you are reading this piece on another publication, it was copied illegally and republished in violation of U.S. & international trademark and copyright legislation. The legal version of this piece can be viewed at https://www.wkrb13.com/2018/11/09/meeder-asset-management-inc-acquires-66516-shares-of-endo-international-plc-endp.html.

Endo International Company Profile

Endo International plc, a specialty pharmaceutical company, manufactures and sells generic and branded pharmaceuticals in the United States, Canada, and internationally. The company operates through three segments: U.S. Generic Pharmaceuticals, U.S. Branded Pharmaceuticals, and International Pharmaceuticals.

Recommended Story: How are institutional investors different from individual investors?

Want to see what other hedge funds are holding ENDP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Endo International PLC (NASDAQ:ENDP) (TSE:ENL).

Institutional Ownership by Quarter for Endo International (NASDAQ:ENDP)

Receive News & Ratings for Endo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Endo International and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply